Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.43), $0.13 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.